INS and metabolic dysfunction-associated steatotic liver disease: In total, 28 subjects (21%) had neither insulin-resistant NAFLD nor an insulin secretion deficit and would resemble the “low-risk” phenotype of TULIP, while the remaining 103 subjects combined (79%) were representative of the TULIP “high-risk” phenotype.